Vicapsys Life Sciences VICP Cash Flow Statement (2019-2024)

OTC VICP
$0.79 -0.06 (-7.06%)
At close: Sep 25, 2026 · 4:00 PM EDT
Reported Financials

Vicapsys Life Sciences Quarterly Cash Flow Statement

Periods 23 quarters
Latest Sep 2024

Vicapsys Life Sciences reported cash from operations of -$40431.00 and free cash flow of -$40431.00 for the quarter ended Sep 2024, up 62.4% year over year. This cash flow statement covers 23 quarters of results from Mar 2019 through Sep 2024, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Operating Activities
Net Income
-249632.00-364459.00-231615.00-89221.00-80549.0050,230.00-72062.00-111181.00-103858.00-167047.00-180056.00-145081.00-492605.00-211277.00-135693.00-240340.00-594803.00-327072.00-190091.00-235507.00
Share-based CompensationStock Comp.
5,408.005,408.005,408.002,883.001,082.001,082.001,081.001,081.001,082.001,081.001,081.0041,395.0062,093.0020,697.00100,000.00
Cash from Discontinued OperationsCash from Discont. Ops
Cash from OperationsCash from Ops.
-246480.00-233218.00-25962.00-3332.00-385.00-70806.00-69839.00-180075.00-123254.00-115976.00-84030.00-41079.002,888.00-9957.00-218103.00-107410.00-82054.00-9422.006,166.00-40431.00
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
5,357.007,863.007,862.007,862.007,837.007,822.007,822.007,822.007,863.007,822.007,822.007,824.007,821.0027,844.00
Change in Working Capital
Change in Account PayablesChange Payables
-7613.00105,247.00-23917.00249.0023,671.00-29332.00-4950.00-67718.00-21320.0026,208.0052,485.0025,306.0055,458.0098,807.0059,827.0015,670.00152,221.0093,491.00101,757.0077,274.00
Change in Accured ExpensesChange Accured Exp.
16,408.0063,450.0035,454.00
Other Working Capital ChangesOther WC Changes
3,685.00198.00-1941.002,915.001,665.002,660.00-1742.007,680.00-4138.00498.00-2055.001,229.0069,068.00-25500.00-81949.00-30234.00
Investing Activities
Divestments
100,000.00
Cash from Investing ActivitiesCash from Investing
100,000.00
Financing Activities
Other financing activitiesOther financing
33,585.00
Cash from Financing ActivitiesCash from Financing
175,000.00175,000.00-15001.00-70335.0037,944.00130,000.00
Debt Issuance and Repayment
Current Debt
-6167.00
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
175,000.00
Additional items
Change in Cash
-246480.00-233218.00-25962.00-3332.00-385.0029,194.00140,161.00-5075.0051,746.00-115976.00-84030.008,921.00-12113.00-9957.00227,137.00-177745.00-44110.00-9422.0089,569.00
Free Cash FlowFCF
-246480.00-233218.00-25962.00-3332.00-385.00-70806.00-69839.00-180075.00-123254.00-115976.00-84030.00-41079.002,888.00-9957.00-218103.00-107410.00-82054.00-9422.006,166.00-40431.00
Net Cash FlowNCF
-246480.00-233218.00-25962.00-3332.00-385.0029,194.00-69839.00-5075.0051,746.00-115976.00-84030.00-41079.00-12113.00-9957.00-218103.00-177745.00-44110.00-9422.006,166.0089,569.00

Vicapsys Life Sciences Cash Flow Statement API

Pull Vicapsys Life Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VICP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY